Services

Pharmacovigilance

Human Medicines

Comprehensive pharmacovigilance services for drug safety and regulatory compliance

At Billev Pharma East, we specialize in providing comprehensive pharmacovigilance solutions to ensure drug safety and compliance with EU and international regulations. Our pharmacovigilance system is designed to support Marketing Authorization Holders (MAHs) throughout the product lifecycle, from development to post-marketing surveillance.

Our services include the implementation and maintenance of a robust pharmacovigilance system master file (PSMF), appointment and support of a Qualified Person for Pharmacovigilance (QPPV), preparation of Periodic Safety Update Reports (PSURs), and development of a tailored Risk Management Plan (RMP) in pharmacovigilance.

We follow the latest Good Pharmacovigilance Practice (GVP) guidelines and ensure that all activities are compliant with good pharmacovigilance practices as required by EMA and local authorities. Whether you need full outsourcing or support with specific PV activities, our experienced team is ready to deliver reliable, efficient, and regulatory-compliant solutions.

In addition to core pharmacovigilance services, we offer strategic guidance in the setup and optimization of your internal pharmacovigilance system, including training, SOP development, and quality assurance aligned with good pharmacovigilance practice (GVP). Our proactive approach ensures early detection of safety signals and efficient handling of benefit-risk evaluations. Whether you’re preparing for market launch or scaling your operations, we provide end-to-end support tailored to your product-specific safety profile. Our extensive experience in working with diverse therapeutic areas allows us to adapt your risk management plan in pharmacovigilance to the unique characteristics of each medicinal product.

All our pharmacovigilance activities are handled by qualified professionals with extensive regulatory knowledge and hands-on experience. As your trusted partner, we take responsibility for the entire safety function, from signal detection and case processing to the preparation of high-quality Periodic Safety Update Reports (PSURs) and maintenance of your Pharmacovigilance System Master File (PSMF). With a dedicated Qualified Person for Pharmacovigilance (QPPV) at your disposal, you can be confident in your ongoing compliance with both local and EU pharmacovigilance requirements.

Events

  • October 2025New Publication in Therapeutic Innovation & Regulatory Science: Our colleague, Jana Brajdih Čendak, has published an expert article on strengthening drug safety through enhanced pharmacovigilance. The article discusses the latest strategies and challenges in the field of monitoring and assessing drug safety after market authorization.

 

  • November 2025 – European Pharmacovigilance Congress 2025 (19–20 Nov online + 28 Nov in Milan, Italy): Martina Prevolšek and Elena Radchenko attended this major gathering of pharmacovigilance professionals. The event covered advanced topics such as modern signal-detection methods, benefit-/risk evaluation, real-world data in PV, AI applications, regulatory trends, and global audit/inspection practices.
How to Reach us?

Billev farmacija vzhod, d. o. o.
Billev Pharma East Ltd.
Tržaška cesta 202

1000 Ljubljana

Slovenia

Our pharmacovigilance services:

  • Help in achieving compliance with the guidelines on Good Pharmacovigilance Practices (GVP)
  • Services of a QPPV (24/7) with access to medical adviser
  • Establishment and maintenance of the Pharmacovigilance system and
    Pharmacovigilance system master file (PSMF), including Quality System
  • Management of Critical pharmacovigilance processes and business continuity
  • Management and preparation of  adverse drug reaction report to ensure timely, compliant and accurate submission to regulatory authorities
  • Weekly monitoring of scientific literature
  • Ongoing benefit-risk evaluation
  • Preparation of Pharmacovigilance Risk Management Plan and Risk minimisation measures
  • Medical writing (PSUR, RMP, etc.)
  • Signal detection and evaluation
  • Managing PASS, PAES
    Regulatory actions (safety variations, communications with stakeholders, etc.)
  • Electronic transmission of the pharmacovigilance data (Article 57),
    selection of appropriate tool and implementation of a quality system
  • Training of personnel
  • Setting up appropriate contractual arrangements and supervision
  • Pharmacovigilance audit and pre-inspection consultations
More ways,
we can help.

With a focus on expert guidance and strategic insights, we propel your projects forward with confidence, ensuring every step is handled with precision.

Don’t miss out
Follow us on LinkedIn
Watch our
promotional video

HOME

SERVICES

Regulatory Affairs

PharmacoVigilance

Medical Consultancy

Quality / GxP

Digital Consultancy

TEAM OF EXPERTS

ABOUT US

NEWS AND EVENTS

B2B PARTNER LOG-IN